Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alum versus tranexamic acid for symptoms of cervical ectropion
IRCT20160524028059N2Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in Cervical ectopy (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Dyspareunia, Postcoital bleeding and 2 more. Started Aug 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Cervical ectopy
Beyond the preview
Go deeper on IRCT20160524028059N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160524028059N2.